Comparative Study Between Combination Therapy Empagliflozin–Sitagliptin and Empagliflozin–Alogliptin in Addition to Metformin Assessing the Hypoglycemic Effect on Patients Diagnosed With Malignancy and Poorly Controlled Type 2 Diabetes Mellitus As Comorbidity. JOC 2025, 24 (3), 669-674. https://doi.org/10.64149/J.Carcinog.24.3.669-674.